Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +748.27%
#3 ADO Protocol ADO Protocol +101.10%
#4 Cortex Cortex +92.95%
#5 Ontology Gas Ontology Gas +65.75%
#6 Kinesis Silver Kinesis Silver +52.89%
#7 OpenEden OpenEden +43.52%
#8 Magma Finance Magma Finance +31.31%
#9 QuantixAI QuantixAI +23.21%
#10 EXOD EXOD +22.78%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087
Kedudukan dalam Saham #3121
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Harga Saham
$10.33
Modal Pasaran
$6.18B
Perubahan (1 hari)
3.66%
Perubahan (1 tahun)
4.21%
Negara
CN
Perdagangan Gan & Lee Pharmaceuticals. (603087)

Kategori

Healthcare
Hasil untuk Gan & Lee Pharmaceuticals. (603087)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Gan & Lee Pharmaceuticals., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Gan & Lee Pharmaceuticals. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 $11.03B -
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 $34.74B -
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 - -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
 $20.84B -
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 - -
CH